Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

21
Number of overlapping holdings
17.8%
% of XBI's 119 holdings also in GNOM
53.8%
% of GNOM's 39 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XBI |
Weight in GNOM |
Overlap | |
---|---|---|---|---|
NATERA INC | 2.8% | 7.1% | 2.8% | |
VERTEX PHARMACEUTICALS INC | 2.7% | 3.0% | 2.7% | |
ALNYLAM PHARMACEUTICALS INC | 2.7% | 4.5% | 2.7% | |
GILEAD SCIENCES INC | 2.5% | 3.4% | 2.5% | |
BIOMARIN PHARMACEUTICAL INC | 2.0% | 4.8% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to GNOM
INSMED INC | 2.7% | |
NEUROCRINE BIOSCIENCES INC | 2.6% | |
UNITED THERAPEUTICS CORP | 2.6% | |
EXACT SCIENCES CORP | 2.5% | |
AMGEN INC | 2.5% | |
INCYTE CORP | 2.4% | |
BIOGEN IDEC INC | 2.3% | |
MADRIGAL PHARMACEUTICALS, INC. | 2.3% | |
REGENERON PHARMACEUTICALS | 2.3% | |
ABBVIE INC | 2.3% |
XBI Underweight Relative to GNOM
BIONTECH SE SPONSORED ADR | -5.1% | |
VERACYTE INC | -4.6% | |
AGILENT TECHNOLOGIES INC | -4.4% | |
NATERA INC | -4.3% | |
LEGEND BIOTECH CORPORATION SPONSORED | -4.2% | |
BIO-TECHNE CORPORATION | -4.0% | |
GENSCRIPT BIOTECH CORPORATION | -3.8% | |
CRISPR THERAPEUTICS AG | -3.3% | |
ULTRAGENYX PHARMACEUTICAL IN | -2.9% | |
ILLUMINA INC | -2.8% |